#ESMO26 embargo lifted following breach. Detailed data confirm Moderna $MRNA and Merck $MRK cancer vaccine met key endpoints in melanoma trial Personalized mRNA therapy reduced disease recurrence by 42% compared to standard treatment https://t.co/fD16iO2KJm